Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
636
datasets available to search
ShareScore release 0.9.0
Dataset results
636 results for “Chimerism”
Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT02186860. IPD Sharing: Not stated. Countries: 1. Publications: 1.
To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors
ClinicalTrials.gov study NCT05388695. IPD Sharing: NO. Countries: 1. Publications: 1.
Immunotherapy Using Autologous T Cell-Engineered With CD19-specific Chimeric Antigen Receptor for the Treatment of Recurrent /Refractory B Cell Leukemia
ClinicalTrials.gov study NCT02644655. IPD Sharing: Not stated. Countries: 1. Publications: 14.
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
ClinicalTrials.gov study NCT03692429. IPD Sharing: NO. Countries: 2. Publications: 1.
Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT02588456. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
ClinicalTrials.gov study NCT04133636. IPD Sharing: YES. Countries: 8. Publications: 1.
Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies
ClinicalTrials.gov study NCT02315612. IPD Sharing: YES. Countries: 1. Publications: 9.
ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)
ClinicalTrials.gov study NCT04049513. IPD Sharing: YES. Countries: 1. Publications: 4.
Early Chimerism Following Allogeneic Stem-Cell Transplant
ClinicalTrials.gov study NCT03689907. IPD Sharing: NO. Countries: 1. Publications: 13.
A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)
ClinicalTrials.gov study NCT00779883. IPD Sharing: Not stated. Countries: 1. Publications: 51.
Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events
ClinicalTrials.gov study NCT04279470. IPD Sharing: NO. Countries: 1. Publications: 1.
CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL
ClinicalTrials.gov study NCT00586391. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment
ClinicalTrials.gov study NCT01561911. IPD Sharing: Not stated. Countries: 1. Publications: 1.
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
ClinicalTrials.gov study NCT06193889. IPD Sharing: NO. Countries: 3. Publications: 1.
Humanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies
ClinicalTrials.gov study NCT04008251. IPD Sharing: NO. Countries: 1. Publications: 2.
Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma
ClinicalTrials.gov study NCT02992834. IPD Sharing: NO. Countries: 1. Publications: 2.
KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
ClinicalTrials.gov study NCT06342960. IPD Sharing: NO. Countries: 1. Publications: 2.
KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
ClinicalTrials.gov study NCT05938725. IPD Sharing: NO. Countries: 1. Publications: 2.
BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple Myeloma
ClinicalTrials.gov study NCT03093168. IPD Sharing: YES. Countries: 1. Publications: 1.
Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.
ClinicalTrials.gov study NCT03874897. IPD Sharing: YES. Countries: 1. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.